Following a lung cancer diagnosis in 2014, Australian lawyer Lillian Leigh shifted her focus to advocate for those affected by cancer. Lillian was appointed as an Advisory Council member of Cancer Australia in 2018, where she had also served on its Research and Data Advisory Group for three years. She is a non-executive director of the Thoracic Oncology Group of Australasia, an Executive Committee member of Cancer Voices NSW, a Patient Advisory Board member of Rare Cancers Australia, and a proud member of The ROS1ders. Lillian received the IASLC WCLC Patient Advocacy Award at Vienna in 2016, and has assisted in IASLC's Supportive Training and Advocacy in Research and Science (STARS) Program as a Mentor since 2019.

Rebecca D. Pentz, PhD
My position as Professor of Research Ethics is unique in that I am embedded in all aspects of translational science conducted at Winship Cancer Institute. This has made possible cutting-edge empirical ethics research into areas of ethical concern, including informed consent and justice issues in clinical trials. The ethics program, which I lead, is currently addressing disparate enrollment in clinical trials in the United States. I was one of two faculty who conducted a week long course in Research Ethics in Uganda, which addressed the issue of well-resourced countries conducting trials in low-resourced countries. During the Uganda course we directly addressed the issue surrounding HIV trials and stigma. We worked with traveling singers who were attempting to destigmatize HIV and encourage screening. Currently, I am the research ethicist for the Winship Lung SPORE and work actively with lung cancer investigators to ensure that the lung cancer clinical trials are ethical.

see https://jackwestmd.com/bio-cv/

Dr. West is an Associate Clinical Professor in Medical Oncology, a specialist in thoracic oncology, and serves as Executive Director of Employer Services at City of Hope Comprehensive Cancer Center. He was previously Medical Director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle.

Dr. West received an MPhil in Experimental Biology from Cambridge University on a Fulbright Scholarship and a medical degree (magna cum laude) from Harvard Medical School, where Dr. West also conducted research as a Howard Hughes Medical Student Fellow. His postdoctoral training included an internship and residency in internal medicine at the Harvard-affiliated Brigham and Women’s Hospital Boston, MA, followed by a fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle, WA.

In late, 2002, he moved to Swedish Cancer Institute in Seattle, where he served for over 16 years as Medical Director of the Thoracic Oncology Program, overseeing a broad array of clinical care and research responsibilities. In March, 2019, he moved to the Los Angeles area to dedicate his focus on innovative approaches to delivering sub-specialist expertise across a broader geography, using tools such as remote case reviews and telemedicine consultations.

He has authored dozens of papers and chairs several CME programs and symposia internationally on thoracic oncology, novel educational approaches, and social media in cancer care.

In addition to these activities, he is the Founder & President of Global Resource for Advancing Cancer Education (GRACE); Web Editor for JAMA Oncology; regular correspondent for Medscape; and contributing author and section editor in Lung Cancer for UpToDate.

Dr Bhawna Sirohi is a Medical Oncologist at the Apollo Proton Cancer Centre, Chennai, India. She is a global oncologist and is passionate about delivering quality care in LMICs. She started her oncology training in India in 1994 at the Tata Memorial Centre, Mumbai and completed at Royal Marsden NHS Foundation Trust, UK. She has more than two decades of experience as a medical oncologist both in India and UK. She has published more than 120 papers in national and international journals and lectured worldwide.

Dr. Timothy Hanna is a radiation oncologist and clinician scientist at the Ontario Institute for Cancer Research and Queen's University. He is based in the Queen’s University Cancer Research Institute (QCRI) Division of Cancer Care and Epidemiology (CCE), where his research focuses on three translational streams of health services research: quality of care, access to care and health technology assessment.

Dr. Yasushi Goto is currently the Assistant chief, Division of Thoracic Oncology, of National Cancer Center Hospital, Tokyo. He received his medical and doctorate degree in University of Tokyo. His current main researches are medical oncology (thoracic malignancies) and translational medicine. He has engaged in more than 50 scientific papers including JTO, JCO, Lancet and NEJM. He is a member of steering committee in several global and domestic studies, and the primary investigators of JCOG trial which is evaluating the efficacy of discontinuing PD-L1 axis inhibitors, and others.
He is also a staff in Section of Knowledge Integration of Center for Cancer Genomics and Advanced Therapeutics and Rare Cancer Center, director of patient supportive organizations, secretary general of JSMO (Japanese Society of Medical Oncology), panel member of guideline and database committee in Japanese Lung Cancer Society, associate editor of Japanese Journal of Clinical Oncology and communication committee member of IASLC.

Magdalena Cedzynska, psychologist, psychotherapist, senior researcher, director of smoking cessation service at Cancer Centre. She has been working in National Research Institute of Oncology since 2001. From the very beginning of her work she is in charge of National Quitline and walk-in smoking cessation clinic.
She is engaged in cancer primary prevention through tobacco control with special attention to treatment of tobacco dependence. For more than 12 years she took part as a researcher and coordinator in many national and international projects, clinical trials and observations.
She coordinates first “Open-label observation of effectiveness and safety of cytisine in smoking cessation”, which results were published in Tobacco Control. In years 2007-2010 She was coordinator and investigator in clinical trial “The effects of Tabex (cytisine) on success of attempts to stop smoking”, which results in New England Journal of Medicine.
In years 2009-2011 investigator in internal projects „Tobacco smoking and survivals in non-small cell lung carcinoma treated with radiochemiotherapy”, „Treatment of tobacco dependence of patients with diagnosed cancer of head or neck” , „Change in lifestyle and way of coping with stress and results of treatment of patients with diagnosed cancer of head or neck.”
She contributed to development of Consensus of Medical Health Care Providers on Diagnosis and Treatment of Tobacco Dependence. She has been coordinated and lectured of over 50 courses on tobacco dependence treatment for health professionals all over the Poland.
As a member of International Network of Women Against Tobacco (INWAT) Europe Advisory Board she is interested and engaged especially in women and tobacco control issues.
She is co‐author over 20 scientific publications (peer‐reviewed), 7 books, chapters, monographs and educational programs. She gave many oral presentations at conferences, abstracts and posters.